Key Quantitative Figures
The Nomination and Remuneration Committee, at its meeting held on August 06, 2026, approved the grant of a total of 507,884 options under the following five Employee Stock Option Schemes (ESOS):
- Le Travenues Technology - Employees Stock Option Scheme 2012 (ESOS 2012): 13,156 options
- Le Travenues Technology - Employees Stock Option Scheme 2016 (ESOS 2016): 13,160 options
- Le Travenues Technology - Employees Stock Option Scheme 2020 (ESOS 2020): 4,000 options
- Le Travenues Technology - Employees Stock Option Scheme 2021 (ESOS 2021): 451,528 options
- Le Travenues Technology - Employees Stock Option Scheme 2024 (ESOS 2024): 26,040 options
Pricing and Conversion Details
- The exercise price for all granted options is ₹93 (Rupees Ninety-Three) per option.
- Upon vesting and exercise, each option will be converted into one equity share, resulting in the issuance of up to 507,884 new equity shares on a pari passu basis with existing shares.
Vesting Schedule
The options will vest over a period of four years in equal annual instalments of 25% each.
Exercise Period
- The exercise period for vested options is five years from the date of each respective vesting.
- If an employee resigns, any vested options can be exercised within 365 days from their last working day with the Company.
- Options that are not exercised within their applicable period will lapse.
Committee Meeting Details
The Nomination and Remuneration Committee meeting commenced at 03:45 P.M. (IST) and concluded at 03:55 P.M. (IST) on August 06, 2026.
Stated Rationale and Scheme Objectives
The disclosure states the objectives of the ESOP schemes are to:
- Motivate and retain talented employees to contribute towards the overall growth and profitability of the Company.
- Attract and retain appropriate human talent.
- Align employee interests with the long-term interests of the Company to achieve sustained growth and shareholder value creation.
- Create a sense of ownership and participation amongst employees.
- Provide additional deferred rewards to employees.
Other Disclosures
- No options have been exercised, lapsed, or had their terms varied as part of this grant.
- The money realized by exercise of options and the diluted earnings per share impact are stated as 'Not Applicable' for this disclosure.
- The announcement is also available on the company's investor website: https://investors.ixigo.com/